455 related articles for article (PubMed ID: 22446114)
21. Surveillance of adverse events following immunisation: Australia 2002 to 2003.
Lawrence G; Boyd I; McIntyre P; Isaacs D
Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056
[TBL] [Abstract][Full Text] [Related]
22. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
23. Vaccine safety.
Labadie J
Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
[TBL] [Abstract][Full Text] [Related]
24. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
[TBL] [Abstract][Full Text] [Related]
25. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
26. Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.
Parrella A; Gold M; Marshall H; Braunack-Mayer A; Watson M; Baghurst P
Hum Vaccin Immunother; 2012 May; 8(5):662-7. PubMed ID: 22634441
[TBL] [Abstract][Full Text] [Related]
27. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
[TBL] [Abstract][Full Text] [Related]
28. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
[TBL] [Abstract][Full Text] [Related]
29. Relationship between intention of novel influenza A (H1N1) vaccination and vaccination coverage rate.
Kwon Y; Cho HY; Lee YK; Bae GR; Lee SG
Vaccine; 2010 Dec; 29(2):161-5. PubMed ID: 21055495
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of adverse events following immunisation: Australia, 2000-2002.
Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D
Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057
[TBL] [Abstract][Full Text] [Related]
31. The adverse events of influenza A (H1N1) vaccination and its risk factors in healthcare personnel in 18 military healthcare units in Korea.
Hwang SM; Choe KW; Cho SH; Yoon SJ; Park DE; Kang JS; Kim MJ; Chun BC; Lee SM
Jpn J Infect Dis; 2011; 64(3):183-9. PubMed ID: 21617300
[TBL] [Abstract][Full Text] [Related]
32. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
Clothier HJ; Crawford N; Russell MA; Buttery JP
Euro Surveill; 2017 May; 22(20):. PubMed ID: 28552101
[TBL] [Abstract][Full Text] [Related]
33. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
[TBL] [Abstract][Full Text] [Related]
34. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB
Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268
[TBL] [Abstract][Full Text] [Related]
35. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
[TBL] [Abstract][Full Text] [Related]
36. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
Härmark L; van Hunsel F; Hak E; van Grootheest K
Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
[TBL] [Abstract][Full Text] [Related]
37. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study.
Choe YJ; Bae GR; Lee DH
Vaccine; 2012 Dec; 30(52):7439-42. PubMed ID: 23088885
[TBL] [Abstract][Full Text] [Related]
38. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
Schumacher Z; Bourquin C; Heininger U
Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
[TBL] [Abstract][Full Text] [Related]
39. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
[TBL] [Abstract][Full Text] [Related]
40. Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.
Kraigher A; Ucakar V
Vaccine; 2010 Jul; 28(33):5467-72. PubMed ID: 20598408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
